Melanoma Stage II
Oncology
6 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Lenvatinib | KYNTRA BIO INC. (KYNB) |
Phase 2(4)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| BNT111 | BioNTech SE (BNTX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Melanoma Stage II?
BioSniper tracks 6 drugs in development for Melanoma Stage II across 3 companies.
How many clinical trials target Melanoma Stage II?
There are 1 clinical trial targeting Melanoma Stage II tracked by BioSniper.
Deep-dive into Melanoma Stage II
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis